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Objectives:  Renal  cell  carcinoma  (RCC)  in which  clear  cells  with  papillary  architecture  are
present  is a difﬁcult  diagnostic  challenge.  Clear  cell  RCC,  rarely  has  papillary  architecture.
Papillary  RCC  rarely  contains  clear  cells.  However,  two recently  described  types;  clear  cell
papillary  and  Xp11  translocation  RCC  characteristically  feature  both  papillary  and  clear
cells. Accurate  diagnosis  has both  prognostic  and  therapeutic  implications.  This  study  aims
to highlight  the  helpful  features  of  each  of  these  entities  to enable  reproducible  classiﬁca-
tion.
Methods:  Sixty  RCC  cases  with  clear  cells  and  papillary  architecture  were  selected  and
classiﬁed  according  to  The  International  Society  of Urological  Pathology  (ISUP)  Vancou-
ver Classiﬁcation  of Renal  Neoplasia  and  graded  according  to The  International  Society  of
Urological  Pathology  (ISUP)  grading  system  for renal  cell carcinoma  then  stained  for CK7,
carbonic  anhydrase  IX  (CA  IX), -methylacyl-CoA-racemase  (AMACR)  and TFE-3.
Results:  The  characteristic  immunoproﬁle  of Clear  RCC is CK7−, AMACR−,  CA  IX+  and  TFE3−,
papillary  RCC  is CK7+,  AMACR+,  CAIX−  and  TFE3−, while  for clear  cell  papillary  RCC  it is
CK7+,  AMACR−,  CAIX+  and  TFE3−  and  lastly  Xp11  translocation  RCC  is CK7−,  AMACR+,
CAIX−  and  TFE3+.
Conclusions:  Staining  for  CA  IX,  CK7,  AMACR  and  TFE3  comprises  a concise  panel  for  distin-
guishing  RCC  with  papillary  and  clear pattern.
©  2015  Saudi  Society  of  Microscopes.  Published  by Elsevier  Ltd.  All  rights  reserved.1. Introduction
Renal epithelial tumors are renal neoplasms arising
from renal tubules and can be classiﬁed into many major
categories based on morphology [1]. Different tumor type
appears to have different outcome. With increased under-
standing of pathogenesis of each type of tumors, new target
therapy may  be developed [2].
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2213-879X/© 2015 Saudi Society of Microscopes. Published by Elsevier Ltd. All riPrimary renal cell carcinomas (RCCs) with both pap-
illary architecture and cells with clear cytoplasm may
be a difﬁcult diagnostic challenge. The most common
RCC, clear renal cell carcinoma, CRCC, which represent
about 75% of the cases, may  sometimes have papillary
architecture. The second most common RCC, papillary
renal cell carcinoma, PRCC which represent about 15%,
may  also contains clear cells [3]. However, two recently
described but less-common RCCs, clear cell papillary renal
cell carcinoma, CPRCC and Xp11 translocation RCC, char-
acteristically feature both papillary architecture and cells
with clear cytoplasm. Accurate diagnosis of these distinct
entities has prognostic and therapeutic implications [4].
Immunohistochemical markers may  be needed to establish
the correct diagnosis [5].
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CPRCC is a recently recognized renal neoplasm, com-
osed of an admixture of cystic, glandular, and papillary
omponents, all lined by cells with clear cytoplasm, usu-
lly of low nuclear grade. The nuclei are characteristically
ocated away from the basement membrane to show a
piano-key-like” pattern [3]. The outcome data are limited;
owever, the available data suggest that this type of tumor
sually have a good prognosis. Originally they were dis-
overed in a background of end-stage renal disease and
cquired cystic kidney disease [6].
Xp11 translocation RCC was initially described in chil-
ren and young adults. Recently, the term “MiTF/TFE family
ranslocation-associated carcinoma” has been proposed
or tumors that have translocations involving TFE3. TFE3
s transcription factor that belong to the same family of
ranscription factors that will overexpress nuclear TFE3.
hese immunohistochemical ﬁndings are important given
he occurrence of these tumors in the adult population,
s they morphologically overlap with CCRCC and PRCC. In
he literature, these tumors do not appear to respond to
mmunotherapy [7]. Outcome data of this entity are still
remature and good long-term follow-up data are nec-
ssary. Published outcome series in adults show a poor
rognosis [4].
The treatment paradigm for renal tumors are changing,
nd these changes are in part driven by tumor classiﬁcation.
raditionally, RCC has been considered a surgical disease.
n some cases, surgery with its associated complications
nd negative impact on long-term renal function may  be
ery harmful, so follow up after chemo radiotherapy may
e used in low grade small tumors [8].
Cytokeratins are a family of intermediate ﬁlaments that
haracterize epithelial differentiation, There have been
onﬂicting results on the expression of CK7 in renal epithe-
ial tumors in the literature as some authors recognized its
ole in the differentiation of “non-clear cell” RCC from CRCC
9].
The most useful positive immunohistochemical stain in
upporting a diagnosis of PRCC is -methylacyl-coenzyme
 racemase (AMACR). It is now recognized that AMACR can
how positivity in tumors from many different organs and
n several different types of renal tumors. But AMACR stain-
ng has conﬂicting results in CPRCC as it is often negative
10] but in other studies it is focally or, rarely, diffusely
ositive [6].
Carbonic anhydrase IX (CA IX) protein is thought to
lay a role in the regulation of cell proliferation and may
e involved in oncogenesis and tumor progression. Pre-
ious immunobiochemical studies revealed that CA IX
xpression may  be a useful diagnostic biomarker in RCC
ubclassiﬁcation. Clinical tumor targeting studies with a
onoclonal antibody to CA IX have shown that CA IX shows
romise as a marker for selecting patients with advanced
isease who would beneﬁt from certain speciﬁc systemic
gents, speciﬁcally interleukin-2 (IL-2) [7,11].
This work aims to highlight the helpful cytomorphologic
nd immunohistochemical features of each of these enti-
ies to enable reproducible classiﬁcation. We  examined the
xpression of 4 markers in a series of the 4 major renal cell
umors with clear and papillary architecture. In this study,
e evaluated the expression of carbonic anhydrase IX (CAd Ultrastructure 3 (2015) 68–74 69
IX), -methylacyl-CoA-racemase (AMACR), CK7 and TFE-3
for differential diagnosis and subclassiﬁcation.
2. Materials and methods
2.1. Case selection and histopathological study
A retrospective study was  performed on RCC cases
selected from January 1, 2010 to April 30, 2014. A total of
250 cases of RCC were removed by nephrectomy either par-
tial or radical and brought to the Department of Pathology,
University of Tanta. Representative tissue sections from the
surgical specimens were ﬁxed in 10% buffered formalin
and embedded in parafﬁn. For routine microscopy, 4 -
thick sections were stained with Hematoxylin and Eosin
(H&E). The clinical sheets for all cases were reviewed. The
cases were classiﬁed according to The International Soci-
ety of Urological Pathology (ISUP) Vancouver Classiﬁcation
of Renal Neoplasia [12]. Tumors that fulﬁll the morpho-
logical criteria of clear and papillary renal cell neoplasms
were selected. They were 60 cases. Only the selected cases
were assessed for size, laterality, multifocality, presence
of associated end-stage renal disease (ESRD). Then they
were assessed histologically for the presence of branched
tubular structures, subnuclear vacuoles, acini, thin walled
sinusoid-like vessels, ‘secretory’ cells with nuclei aligned
at the apical end of the cells, cystic components, character
of the stromal compartment, presence of tumor pseudo-
capsule, and calciﬁcation. The selected carcinomas were
later reevaluated for morphologic characteristics of those
tumors that qualify them in either one of the following cat-
egories: CRCC, PRCC, CCPRCC or Xp11 translocation RCC.
Speciﬁcally, the criteria used for classiﬁcation of a tumor
as a CCPRCC included the following: (1) diffuse cytoplas-
mic  clarity; (2) papillary, tubular or cystic architecture; and
(3) characteristic linear arrangement of the nuclei away
from the basement membrane [10]. Xp11 translocation
RCC cases were conﬁrmed by TFE3 immunostaining pos-
itivity. The International Society of Urological Pathology
(ISUP) grading system for renal cell carcinoma grading sys-
tem was applied to assess the nucleolar grades [13]. The
tumors were staged according to the 2010 UICC/AJCC con-
sensus guidelines [14].
2.2. Immunohistochemical study and evaluation
Immunohistochemical staining was  performed using
the following antibodies: CK7 (OV-TL 12/30, 1:100, DAKO,
Glostrup, Denmark), CA IX (dilution 1:200, mouse mono-
clonal, Leica), AMACR (13H4, 1:100; DAKO, Glostrup,
Denmark) and TFE3 (1:1500, Santa Cruz Biotechnology Inv.,
Santa Cruz, CA, USA).
Evaluation of the immunohistochemical staining was
performed by light microscopy using a 10× objective
lens with the selective use of a 20–40× objective lens
for conﬁrmation. The interpretation of immunoreactivity
was performed in a semiquantitative manner by analyz-
ing the extent of the staining positivity of the tumor cells.
Immunostaining of greater than 10% of tumor cells was
required for scoring as a positive case. The interpreta-
tion score was  as follows: 0 or negative ≤10% tumor cell
scopy an70 H.A. Alshenawy / Journal of Micro
positivity; +1 or weak = 11–25% tumor cell positivity; +2 or
moderate = 26–50% tumor cell positivity; and +3 or strong
>50% tumor cell positivity [6]. Cytoplasmic and/or mem-
branous expression of CK7 and AMACR were considered
positive. Only distinct membranous staining for CA IX and
distinct nuclear staining for TFE3 were considered positive
[15].
2.3. Statistical analysis
The clinicopathological and immunohistochemical fea-
tures were tested for their association with the histological
subtype using Student’s t-test for continuous variables and
the chi-square test (or Fisher’s exact test) for qualitative
variables. All statistical analyses were performed using the
SPSS 13.0 software. Statistical signiﬁcance was considered
when P value ≤0.05.
3. Results
3.1. Clinicopathologic ﬁndings of the selected cases
The clinicopathologic ﬁndings are listed in Table 1. The
selected cases were comprised of 60 cases; 40 men  and
20 women (men to women ratio, 2:1) with a mean age of
54 years (range, 40–72 years). A deﬁnite positive history of
hemodialysis was found in 14 cases end stage renal disease
with a duration ranging from 1 to 24 years. Applying the
ISUO grading system, the following grades were identiﬁed:
24 were grade I, 21 were grade II and 15 were grade III.
The tumors pathologic stage was as follows; 38 cases were
stage I, 15 were stage II, 7 were stage III and no cases were
stage IV.
Overall, of the 60 cases, 28 (47%) were CRCC, 15 (25%)
PRCC, 8 (13%) CPRCC and 9 (15%) Xp11 translocation RCC
Table 1
The clinicopathological variables of the selected cases.
Clinicopathological variable Number of
cases
Size Less than 7 cm 45
More than 7 cm 15
Laterality Right 30
Left 24
Bilateral 6
Multifocality Yes 8
No 52
End stage renal disease Yes 14
No 46
Grade Grade I 24
Grade II 21
Grade III 15
Stage Stage I 38
Stage II 15
Stage III 7
Stage IV 0
Histological types CRCC 28
PRCC 15
CPRCC 8
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were identiﬁed. The cases were classiﬁed according to the
published data into these categories according to some
variables summarized in Table 2.
CRCC were usually characterized by clear cytoplasm
and a well-deﬁned cytoplasmic membrane. The cells were
arranged in nests, alveolar architectures and papillae. The
stroma contained a very typical and prominent capillary
network. Hemorrhage and necrosis were frequent (Fig. 1a).
PRCC showed prominent papillary architecture. Deli-
cate ﬁbrovascular stalks were lined by small cells with low
grade nuclei and scant cytoplasms (Fig. 2a). Psammoma
bodies and clear cells were common.
CPRCC were well circumscribed with a well-deﬁned,
thin, ﬁbrous capsule and were composed histologically of
a mixture of cysts and papillae. Tubular features were also
common. Even in the predominantly cystic areas, the lining
cells frequently showed papillary infoldings. The tumors
were composed of cuboidal cells with clear cytoplasm,
small hyperchromatic, round nuclei, and inconspicuous
nucleoli. A conspicuous nuclear positioning away from
the basement membrane with subnuclear vacuoles was
noted in all cases examined (Fig. 3a). Renal capsular and
vascular invasion, mitoses, tumor necrosis, and stromal
aggregates of macrophages were not observed so the bio-
logical aggressiveness of this type is usually considered
very low. The stromal component formed variably thick
bands of ﬁbrous tissue admixed with strands of leiomy-
omatous tissue inside the tumors.
Renal carcinomas with Xp11.2 translocation have a
characteristic morphology; they are composed of very large
clear cells that form nests, alveoli, and papillae (Fig. 4a)
accompanied by many psammoma  bodies. The cells are not
very cohesive, which causes alveolar images and pseudo
papillae.
3.2. Correlation study between the studied cases and
clinicopathological variables
In correlation between the different pathological types
of RCC and the clinicopathological variables, it was  found
that there is a signiﬁcant difference between the histolog-
ical type of RCC and the tumor size as most of the cases
of PRCC, Xp11.2 translocation RCC (12/15 and 7/9 respec-
tively) and all the cases of CPRCC were of smaller size
(≤7 cm)  while most of the large sized tumors were CRCC. As
regards the laterality, PRCC was the most common bilateral
RCC (5/15) as 5 cases out of the 6 bilateral cases were PRCC
with statistical signiﬁcant difference. Also the multifocal-
ity was only seen in PRCC (8/15) as all the multifocal cases
were PRCC with strong statistical difference. Most of the
cases with end stage renal disease (14 cases) were associ-
ated with either CPRCC (6/8) or CRCC (6/28) with statistical
signiﬁcance.
The grade was  correlated signiﬁcantly with RCC types
as it was low in all the cases of CPRCC (either grade
I or II). On the other hands, more than half of the
Xp11 translocation RCC cases were of high grade (grade
III). The tumor stage was  also low in most of the
cases of CRCC, PRCC and all the cases of CPRCC and
the stage was high prominently in XP11 with strong
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Table  2
Microscopic ﬁnding in the selected cases.
Histological features CRCC PRCC CPRCC Xp11 translocation
Clear cells Yes Yes Yes Yes
‘Secretory’ cells with nuclei aligned at the apical end of the cells No No Yes No
Subnuclear vacuoles No No Yes No
True  papillae No Yes Yes Yes
Tubules No No Yes Yes
Cysts  Yes Yes Yes Yes
Acini  Yes No Yes Yes
Biologic aggressiveness Yes Yes No Yes
The  presence of capsule No Yes Yes No
Psammoma bodies No Yes No No
Leiomyomatous stromal components Yes No Yes Yes
Thin  walled sinusoid-like vessels Yes No No No
Fig. 1. A case of CRCC grade I showing clear cells with faint stroma (H&E 100×, a) showing positive membranous staining for CA IX (400×, b) and week
positivity for both CK7 (200×, c) and AMACR (400×, d).
Fig. 2. A case of PRCC grade II showing prominent papillae with occasional clear cells (H&E 100×, a). It expresses strong membranous positivity for CK7
(200×,  b). AMACR demonstrates cytoplasmic granular positivity (200×, c).
Table 3
Correlation study between the studied cases and clinicopathological variables.
Histological type Size Laterality Multifocality ESRD Grade Stage
≤7 cm,
n = 45
>7 cm,
n = 15
Rt,
n = 30
Lt,
n  = 24
Bilateral,
n  = 6
Yes,
n = 8
No,
n = 52
Yes,
n = 14
No,
n  = 46
I,
n = 24
II,
n = 21
III,
n = 15
I,
n = 38
II,
n = 15
III,
n = 7
IV,
n  = 0
CRCC, n = 28 18 10 15 13 0 0 28 6 22 10 15 3 12 12 4 0
PRCC,  n = 15 12 3 6 4 5 8 7 1 14 6 2 7 13 1 1 0
CPRCC,  n = 8 8 0 3 4 1 0 8 6 2 5 3 0 8 0 0 0
Xp11.2
translocation
RCC,  n = 9
7 2 6 3 0 0 9 1 8 3 1 5 5 2 2 0
P  value 0.01 0.04 0.003 0.05 0.04 0.008
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 charact
X diffusFig. 3. A case of CPRCC grade I show clear cells with low grade nuclei show
a),  it demonstrates positive cytoplasmic staining for CK7 (200×, b), CA-I
(400×,  c).
signiﬁcant difference. These data were summarized in
Table 3.
3.3. Immunohistochemical ﬁndings in the studied cases
The immunohistochemical ﬁndings are listed in Table 4.
All the cases of CRCC showed positive membranous
staining for CA IX (18/28 and 10/28 were strongly posi-
tive (Fig. 1b) and moderately positive consequently), while
they most the cases were negative for both CK7 and AMACR
(except 2/28 (Fig. 1c) and 5/28 (Fig. 1d) were weak positive
respectively). TFE3, marker of Xp11 translocation RCC, is
consistently negative.
All PRCC cases showed strong membranous positivity
for CK7 (Fig. 2b). AMACR staining demonstrated cytoplas-
mic  granular positivity in all the cases (Fig. 2c). The CA IX
staining is either completely negative (13/15) or may  be
weak positive near areas of necrosis (2/15). TFE3 is consis-
tently negative.
CPRCC displays a unique IHC proﬁle overlapping with
CRCC and PRCC. CPRCC showed positive cytoplasmic stain-
ing for CK7 in all the cases (Fig. 3b); similar to PRCC. AMACR,
TFE3 were negative in all the cases examined. The tumor
cells also expressed CA-IX diffusely in a membranous
distribution (6/8 and 2/8 were strongly and moderately
positive consequently); the absence of staining along the
luminal borders of the tumor cells was characteristic
Fig. 4. A case of Xp11 translocation grade II shows clear cells and papillary archit
in  the cytoplasm (200×, b), and characteristically show nuclear positivity for TFEeristic linear polarization away from the basement membrane (H&E 200×,
ely expressed in a membranous distribution in cup-shaped distribution
(cup-shaped distribution) (Fig. 3c). TFE3 is consistently
negative.
Most of the cases of Xp11.2 translocation RCC did not
express CK7 and CA IX (8/9 and 7/9 were negative for CK7
and CA IX respectively) but they all expressed AMACR (6/9
were strongly (Fig. 4b) and 3/9 were moderately positive
respectively). In addition, this group of carcinomas is char-
acterized by nuclear positivity with the TFE3 transcription
factor (Fig. 4c).
4. Discussion
The World Health Organization classiﬁcation of renal
tumors synthesizes morphological, immunohistochemi-
cal, molecular, and clinical data to deﬁne distinct entities
that are biologically and clinically relevant. Although most
epithelial renal tumors can be diagnosed by morphology
alone, the diagnosis can be difﬁcult due to the over-
lap of histological features. In these cases, differentially
expressed immunohistochemical markers can be of help
[2]. In this study, we performed a 4-antibody panel on RCC
cases that show both papillary and clear cell architecture.
The present study included 60 cases consist of CRCC,
PRCC, CPRCC and Xp11.2 translocation RCC. Most of PRCC,
Xp11.2 translocation RCC and all CPRCC cases were of
smaller size (≤7 cm). PRCC was  found to be the most com-
mon  bilateral and multifocal RCC. End stage renal disease
ecture with high grade nuclei (H&E 200×, a), strongly expressing AMACR
3 (200×, c).
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Table  4
Immunohistochemical proﬁle of the studied cases.
Studied marker CRCC
N = 28
PRCC
N = 15
CPRCC
N = 8
Xp11 translocation
N  = 9
CreK7
Negative 26 0 0 8
+  2 0 0 1
++  0 0 0 0
+++ 0 15 8 0
AMACR
Negative 23 0 8 0
+  5 0 0 0
++  0 0 0 3
+++ 0 15 0 6
CA  IX
Negative 0 13 0 7
+  0 2 0 2
++  10 0 2 0
+++ 18 0 6 0
TFE3
Negative 28 15 8 0
+  0 0 0 0
++  0 0 0 0
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as associated with most of CPRCC but also we observed
hat CPRCC can occur in otherwise normal kidneys and this
as observed in Michelle et al. study [10].
CRCC was usually of aggressive architecture as it was
haracterized by tumor necrosis, mitoses, vascular inva-
ion, and a characteristic network of small, thin-walled
inusoid-like blood vessels, so it was usually presented
ith higher stage and this was seen in Brannon et al. study
16]. PRCC usually has cystic change and papillary architec-
ure. Clear cell change can become quite extensive in some
umors causing morphologic confusion. The cytoplasmic
learing is typically seen in association with tumor necrosis
nd this was similar to Aydin et al. study [17].
CPRCC were well circumscribed with a well-deﬁned
brous capsule, and were composed of a mixture of cystic,
apillary, tubular, and acinar components. The nuclei show
haracteristic polarization in a linear array away from the
asement membrane and of low grade. The stromal com-
onent formed variably thick bands of ﬁbroleiomyomatous
issue inside the tumors among the epithelial component.
hese features were observed in previous studies [10,18].
Xp11.2 translocation RCC has a distinctive pattern
hich is the presence of both clear cells and papillary archi-
ecture. Nuclei tend to be high grade and the cytoplasm
ay  be clear to granular and eosinophilic. Numerous psam-
omatous calciﬁcations and stromal hyaline nodules are
ommon. Most of our cases were of higher grades and this
as similar to Rajen et al. [7].
The distinction between CRCC, PRCC, CPRCC and Xp11.2
ranslocation RCC is critical because of different behavior,
rognosis and treatment [6].
In the present study, the grade was low in all the cases
f CPRCC, and the stage was also low in most of the cases
f CRCC, PRCC and all the cases of CPRCC with strong sig-
iﬁcant difference. On the basis of our results, it appears
hat CPRCC represents a distinct form of low grade RCC, the
ecognition of which may  be important for prognosis and
linical management no case of CPRCC has behaved aggres-
ively as in previous studies [19]. So immunohistochemical0 0 9
study to differentiate difﬁcult cases may  be needed to clas-
sify them.
CK7 is a commonly used marker for RCC. Our results
showed diffuse positivity for this marker in a membranous
pattern, consistent with previous reports [20], conﬁrming
its usefulness in differentiating both PRCC and CPRCC from
CRCC and Xp11 translocation RCC which is consistently
negative in both.
AMACR is a mitochondrial enzyme, which mediates the
oxidation of branched-chain lipids. In this study, it has been
shown that this marker is usually positive in PRCC and
Xp11 translocation RCC with a diffuse strong cytoplasmic
staining pattern. Our study showed that AMACR was usu-
ally negative or weekly positive in CRCC while CPRCC was
negative for this marker, consistent with prior reports [2,3].
CA IX is a hypoxia-induced protein and is predominantly
reported to be positive in CRCC [2,21]. In this study, CPRCC
is largely positive for this marker, a result that concurs
with previous observations [11]. CA IX is useful for the
differentiation of CRCC and CPRCC from PRCC with clear
cell changes. CRCC and CPRCC are usually positive for this
marker, whereas the PRCC is either completely negative
or may  be weekly positive near areas of necrosis. How-
ever, the pattern of expression of CA IX in CPRCC differs
from that seen in CRCC in that most cells in clear-cell pap-
illary RCC lack labeling on the luminal aspect. This pattern
of staining was  not observed in any of the CRCCs evaluated
in this study and this was in agreement with Stephen et al.
[15] and Tickoo and Reuter [22]. Xp11 translocation RCC
diagnosis is supported by TFE3 positivity.
In summary, the characteristic immunoproﬁle of CRCC
is CK7−, AMACR−, CA IX+ and TFE3−, for PRCC it is CK7+,
AMACR+, CA IX− and TFE3−, while for CPRCC it is CK7+,
AMACR−, CA IX+ and TFE3− and lastly Xp11 translocation
RCC is CK7−, AMACR+, CA IX− and TFE3+.To conclude, immunohistochemical staining for CA
IX, CK7, AMACR and TFE3 comprises a concise panel
for distinguishing RCC with papillary and clear pattern.
Our marker panel is a clear advancement in terms of
scopy an
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immunohistochemistry application for RCC subtype dif-
ferentiation when papillary and clear cells are the
predominant architecture as this is very crucial for further
prognosis and targeted therapy because of the different
behavior of each type.
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